Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells.

<h4>Background and aim</h4>As a multiple tyrosine kinase inhibitor, sorafenib is widely used to treat hepatocellular carcinoma (HCC), but patients frequently face resistance problems. Because the mechanism controlling sorafenib-resistance is not well understood, this study focused on the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Luping Gao, Yuji Morine, Shinichiro Yamada, Yu Saito, Tetsuya Ikemoto, Kazunori Tokuda, Chie Takasu, Katsuki Miyazaki, Mitsuo Shimada
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/77a88510e3f24172b46a4826846c122e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:77a88510e3f24172b46a4826846c122e
record_format dspace
spelling oai:doaj.org-article:77a88510e3f24172b46a4826846c122e2021-12-02T20:08:33ZNrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells.1932-620310.1371/journal.pone.0256755https://doaj.org/article/77a88510e3f24172b46a4826846c122e2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0256755https://doaj.org/toc/1932-6203<h4>Background and aim</h4>As a multiple tyrosine kinase inhibitor, sorafenib is widely used to treat hepatocellular carcinoma (HCC), but patients frequently face resistance problems. Because the mechanism controlling sorafenib-resistance is not well understood, this study focused on the connection between tumor characteristics and the Nrf2 signaling pathway in a sorafenib-resistant HCC cell line.<h4>Methods</h4>A sorafenib-resistant HCC cell line (Huh7) was developed by increasing the dose of sorafenib in the culture medium until the target concentration was reached. Cell morphology, migration/invasion rates, and expression of stemness-related and ATP-binding cassette (ABC) transporter genes were compared between sorafenib-resistant Huh7 cells and parental Huh7 cells. Next, a small interfering RNA was used to knock down Nrf2 expression in sorafenib-resistant Huh7 cells, after which cell viability, stemness, migration, and ABC transporter gene expression were examined again.<h4>Results</h4>Proliferation, migration, and invasion rates of sorafenib-resistant Huh7 cells were significantly increased relative to the parental cells with or without sorafenib added to the medium. The expression levels of stemness markers and ABC transporter genes were up-regulated in sorafenib-resistant cells. After Nrf2 was knocked down in sorafenib-resistant cells, cell migration and invasion rates were reduced, and expression levels of stemness markers and ABC transporter genes were reduced.<h4>Conclusion</h4>Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant HCC cells.Luping GaoYuji MorineShinichiro YamadaYu SaitoTetsuya IkemotoKazunori TokudaChie TakasuKatsuki MiyazakiMitsuo ShimadaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 9, p e0256755 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Luping Gao
Yuji Morine
Shinichiro Yamada
Yu Saito
Tetsuya Ikemoto
Kazunori Tokuda
Chie Takasu
Katsuki Miyazaki
Mitsuo Shimada
Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells.
description <h4>Background and aim</h4>As a multiple tyrosine kinase inhibitor, sorafenib is widely used to treat hepatocellular carcinoma (HCC), but patients frequently face resistance problems. Because the mechanism controlling sorafenib-resistance is not well understood, this study focused on the connection between tumor characteristics and the Nrf2 signaling pathway in a sorafenib-resistant HCC cell line.<h4>Methods</h4>A sorafenib-resistant HCC cell line (Huh7) was developed by increasing the dose of sorafenib in the culture medium until the target concentration was reached. Cell morphology, migration/invasion rates, and expression of stemness-related and ATP-binding cassette (ABC) transporter genes were compared between sorafenib-resistant Huh7 cells and parental Huh7 cells. Next, a small interfering RNA was used to knock down Nrf2 expression in sorafenib-resistant Huh7 cells, after which cell viability, stemness, migration, and ABC transporter gene expression were examined again.<h4>Results</h4>Proliferation, migration, and invasion rates of sorafenib-resistant Huh7 cells were significantly increased relative to the parental cells with or without sorafenib added to the medium. The expression levels of stemness markers and ABC transporter genes were up-regulated in sorafenib-resistant cells. After Nrf2 was knocked down in sorafenib-resistant cells, cell migration and invasion rates were reduced, and expression levels of stemness markers and ABC transporter genes were reduced.<h4>Conclusion</h4>Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant HCC cells.
format article
author Luping Gao
Yuji Morine
Shinichiro Yamada
Yu Saito
Tetsuya Ikemoto
Kazunori Tokuda
Chie Takasu
Katsuki Miyazaki
Mitsuo Shimada
author_facet Luping Gao
Yuji Morine
Shinichiro Yamada
Yu Saito
Tetsuya Ikemoto
Kazunori Tokuda
Chie Takasu
Katsuki Miyazaki
Mitsuo Shimada
author_sort Luping Gao
title Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells.
title_short Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells.
title_full Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells.
title_fullStr Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells.
title_full_unstemmed Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells.
title_sort nrf2 signaling promotes cancer stemness, migration, and expression of abc transporter genes in sorafenib-resistant hepatocellular carcinoma cells.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/77a88510e3f24172b46a4826846c122e
work_keys_str_mv AT lupinggao nrf2signalingpromotescancerstemnessmigrationandexpressionofabctransportergenesinsorafenibresistanthepatocellularcarcinomacells
AT yujimorine nrf2signalingpromotescancerstemnessmigrationandexpressionofabctransportergenesinsorafenibresistanthepatocellularcarcinomacells
AT shinichiroyamada nrf2signalingpromotescancerstemnessmigrationandexpressionofabctransportergenesinsorafenibresistanthepatocellularcarcinomacells
AT yusaito nrf2signalingpromotescancerstemnessmigrationandexpressionofabctransportergenesinsorafenibresistanthepatocellularcarcinomacells
AT tetsuyaikemoto nrf2signalingpromotescancerstemnessmigrationandexpressionofabctransportergenesinsorafenibresistanthepatocellularcarcinomacells
AT kazunoritokuda nrf2signalingpromotescancerstemnessmigrationandexpressionofabctransportergenesinsorafenibresistanthepatocellularcarcinomacells
AT chietakasu nrf2signalingpromotescancerstemnessmigrationandexpressionofabctransportergenesinsorafenibresistanthepatocellularcarcinomacells
AT katsukimiyazaki nrf2signalingpromotescancerstemnessmigrationandexpressionofabctransportergenesinsorafenibresistanthepatocellularcarcinomacells
AT mitsuoshimada nrf2signalingpromotescancerstemnessmigrationandexpressionofabctransportergenesinsorafenibresistanthepatocellularcarcinomacells
_version_ 1718375189644836864